Saturday, December 21, 2024

HHS SAMHSA awards $260M National Surveys on Drug Use and Health (NSDUH) contract

Notice ID: 283-22-0568
Award Number: 75S20322C00001
Contractor Awarded Name: Research Triangle Institute
Base and All Options Value (Total Contract Value): $260010049.00

“The purpose of this contract is to provide current data on substance use prevalence for the U.S. population, aged 12 years and older, in each state, and to issue reports on survey results.  The National Survey on Drug Use and Health (NSDUH) provides information on the incidence and prevalence of substance use authorized by Section 505 of the Public Health Service Act (42 USC 290aa4). Conducted on a periodic basis from 1971-1988, and annually since 1990, the NSDUH provides current data on substance use prevalence for the U.S. population – aged 12 or older…”

“These data are used by the Substance Abuse and Mental Health Services Administration (SAMHSA)  SAMHSA, the National Institute on Drug Abuse (NIDA), the Centers for Disease Control and Prevention (CDC), the Office of National Drug Control Policy (ONDCP), the National Institute of Mental Health (NIMH), Food and Drug Administration (FDA), and other Federal agencies interested in the prevalence of substance use, in order to: (1) design prevention programs, (2) respond to inquiries on the extent of substance use, (3) estimate treatment need, (4) study the socioeconomic impact of substance abuse, (5) identify correlates of substance use, and (6) evaluate the overall impact that Federal and State programs have on drug demand. NSDUH data provide a useful indicator of individual States’ overall success at reducing youth substance abuse.”

Read more here.

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required